Semaglutide and the Risk of Blindness: What We Know So Far
Introduction: Semaglutide, sold under brand names such as Ozempic, Wegovy, and Rybelsus, is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) widely used to manage type 2 diabetes and obesity. Praised for its effectiveness in reducing blood sugar and promoting weight loss, semaglutide has become one of the most prescribed drugs…